- Home
- VALU vs CVRX Comparison
VALU vs CVRX Comparison
Compare VALU & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALU
- CVRX
- Stock Information
- Founded
- VALU 1931
- CVRX 2000
- Country
- VALU United States
- CVRX United States
- Employees
- VALU N/A
- CVRX N/A
- Industry
- VALU Investment Managers
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VALU Finance
- CVRX Health Care
- Exchange
- VALU Nasdaq
- CVRX Nasdaq
- Market Cap
- VALU 510.6M
- CVRX 419.8M
- IPO Year
- VALU N/A
- CVRX 2021
- Fundamental
- Price
- VALU $45.90
- CVRX $17.62
- Analyst Decision
- VALU
- CVRX Strong Buy
- Analyst Count
- VALU 0
- CVRX 7
- Target Price
- VALU N/A
- CVRX $17.00
- AVG Volume (30 Days)
- VALU 6.8K
- CVRX 213.8K
- Earning Date
- VALU 03-14-2025
- CVRX 01-27-2025
- Dividend Yield
- VALU 2.61%
- CVRX N/A
- EPS Growth
- VALU 26.35
- CVRX N/A
- EPS
- VALU 2.36
- CVRX N/A
- Revenue
- VALU $35,859,000.00
- CVRX $47,255,000.00
- Revenue This Year
- VALU N/A
- CVRX $31.78
- Revenue Next Year
- VALU N/A
- CVRX $26.42
- P/E Ratio
- VALU $19.45
- CVRX N/A
- Revenue Growth
- VALU N/A
- CVRX 34.38
- 52 Week Low
- VALU $36.00
- CVRX $6.40
- 52 Week High
- VALU $57.68
- CVRX $29.23
- Technical
- Relative Strength Index (RSI)
- VALU 31.00
- CVRX 76.79
- Support Level
- VALU $48.00
- CVRX $13.82
- Resistance Level
- VALU $49.82
- CVRX $17.72
- Average True Range (ATR)
- VALU 1.20
- CVRX 0.88
- MACD
- VALU -0.69
- CVRX 0.49
- Stochastic Oscillator
- VALU 1.77
- CVRX 98.09
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.